LFWD Key Statistics, Chart & Performance
The current stock price of LFWD is 0.6951 USD. In the past month the price decreased by -11.04%. In the past year, price decreased by -61.62%.
LFWD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.63 | 213.67B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.79 | 200.81B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.97 | 139.79B | ||
| SYK | STRYKER CORP | 27.03 | 136.15B | ||
| IDXX | IDEXX LABORATORIES INC | 57 | 57.40B | ||
| BDX | BECTON DICKINSON AND CO | 13.98 | 57.53B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.44 | 48.38B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.7 | 39.09B | ||
| RMD | RESMED INC | 26.08 | 37.69B | ||
| DXCM | DEXCOM INC | 37.42 | 27.15B | ||
| PODD | INSULET CORP | 61.47 | 19.76B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 17.58B |
Related stock screener links
About LFWD
Company Profile
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Company Info
LIFEWARD LTD
3 Hatnufa st. 6th fl., P.O. Box 161
Yokneam IL
Employees: 80
Phone: 97249590123
LIFEWARD LTD / LFWD FAQ
Can you describe the business of LIFEWARD LTD?
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Can you provide the latest stock price for LIFEWARD LTD?
The current stock price of LFWD is 0.6951 USD. The price increased by 10.44% in the last trading session.
Does LFWD stock pay dividends?
LFWD does not pay a dividend.
What is the ChartMill technical and fundamental rating of LFWD stock?
LFWD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of LIFEWARD LTD (LFWD) based on its PE ratio?
LIFEWARD LTD (LFWD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.86).
What is the employee count for LFWD stock?
LIFEWARD LTD (LFWD) currently has 80 employees.
Can you provide the market cap for LIFEWARD LTD?
LIFEWARD LTD (LFWD) has a market capitalization of 12.71M USD. This makes LFWD a Nano Cap stock.
LFWD Technical Analysis
LFWD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LFWD. LFWD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
LFWD Financial Highlights
Over the last trailing twelve months LFWD reported a non-GAAP Earnings per Share(EPS) of -1.86. The EPS increased by 25.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -127.62% | ||
| ROE | -231.8% | ||
| Debt/Equity | 0 |
LFWD Forecast & Estimates
8 analysts have analysed LFWD and the average price target is 5.27 USD. This implies a price increase of 658.17% is expected in the next year compared to the current price of 0.6951.
For the next year, analysts expect an EPS growth of 51.63% and a revenue growth -2.52% for LFWD